Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 2 , Pages 93-95 , April 2007

Self-Induced Medical Abortion in an Adolescent

  • M.S. Coles, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Mandy Coles, Division of Adolescent Medicine, University of Rochester, 601 Elmwood Avenue, Box 690, Rochester, NY 14642
    • ,
  • L.P. Koenigs, MD

References 

  1. Grunbaum J, Kann L, Kinchen S, et al. Youth Risk Behavior Surveillance—United States, 2003 (Abridged). J Sch Health. 2004;74:1
  2. Elam-Evans L, Strauss L, Herndon J, et al. Centers for Disease Control and Prevention. Abortion surveillance—United States, 2000. MMWR Surveill Summ. 2003;52:1
  3. Blanchard K, Winikoff B, Ellertson C. Misoprostol used alone for the termination of early pregnancy. A review of the evidence. Contraception. 1999;59:209
  4. Schaff EA, Fielding SL, Eisinger SH, et al. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception. 2000;61:41
  5. In:  McEvoy GK editors. AHFS Drug Information. Bethesda: American Society of Health-System Pharmacists Inc; 2001;p. 2837–2842
  6. Coelho KE, Sarmento MF, Veiga CM, et al. Misoprostol embryotoxicity: clinical evaluation of fifteen patients with arthrogryposis. Am J Med Genet. 2000;95:297
  7. Gonzalez CH, Marques-Dias MJ, Kim CA, et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet. 1998;351:1624
  8. Costa SH. Commercial availability of misoprostol and induced abortion in Brazil. Int J Gynaecol Obstet. 1998;63 Suppl:S131
  9. Pongsatha S, Morakot N, Tongsong T. Demographic characteristics of women with self use of misoprostol for pregnancy interruption attending Maharaj Nakorn Chiang Mai Hospital. J Med Assoc Thai. 2002;85:1074
  10. United Nations: Pharmaceuticals: Restrictions in use and availability. Update to the United Nations Consolidated List of Products whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or Not Approved by Governments – Pharmaceuticals. 2003. Available: http://www.who.int/medicines/publications/restrictions/en/. Accessed 4-24-2006
  11. Rosing MA, Archbald CD. The knowledge, acceptability, and use of misoprostol for self-induced medical abortion in an urban US population. J Am Med Womens Assoc. 2000;55:3 Suppl:183
  12. Yanow S, Simmonds, K: When abortion is out of reach, women will find a way: Use of misoprostol for self-induced abortion around the world. 2001. Available: http://www.abortionaccess.org/viewpages.php?id=177. Accessed 4-24-2006

PII: S1083-3188(06)00333-0

doi: 10.1016/j.jpag.2006.10.015

Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 2 , Pages 93-95 , April 2007

Article Tools